Gamma-hydroxybutyric acid efficacy, potential abuse, and dependence in the treatment of alcohol addiction (Q33952019)

30 July 2017

1 reference

title

Gamma-hydroxybutyric acid efficacy, potential abuse, and dependence in the treatment of alcohol addiction (English)

1 reference

30 July 2017

Addolorato G

1

1 reference

30 July 2017

Caputo F

2

1 reference

30 July 2017

Capristo E

3

1 reference

30 July 2017

Stefanini GF

4

1 reference

30 July 2017

Gasbarrini G

5

1 reference

30 July 2017

1 April 2000

1 reference

30 July 2017

1 reference

30 July 2017

20

1 reference

30 July 2017

3

1 reference

30 July 2017

217-222

1 reference

An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group.

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Manageability and tolerability of gamma-hydroxybutyric acid in the medium term outpatient treatment of alcoholism.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: possible craving development for the drug

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Maintaining abstinence from alcohol with gamma-hydroxybutyric acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Patients with alcohol problems.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Gamma-hydroxybutyric acid in the treatment of alcoholism: dosage fractioning utility in non-responder alcoholic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Long-term administration of GHB does not affect muscular mass in alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Gamma-hydroxybutyric acid reducing effect on ethanol intake: evidence in favour of a substitution mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gammahydroxybutyric acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: occurrence within narrow dose ranges.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Cross-tolerance to ethanol and gamma-hydroxybutyric acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Gamma-hydroxybutyric acid intake in ethanol-preferring sP and -nonpreferring sNP rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

gamma-Hydroxybutyrate: a health-food product producing coma and seizurelike activity

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Outcome studies of brief alcohol intervention in general practice: the problem of lost subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Review of neurotransmitters and their role in alcoholism treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Physical dependence on sodium oxybate.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Selective increase of brain dopamine induced by gamma-hydroxybutyrate: study of the mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Mechanism of the antialcohol effect of gamma-hydroxybutyric acid

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

A tale of novel intoxication: seven cases of gamma-hydroxybutyric acid overdose

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid (GHB) and ethanol.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

GHB use in South Carolina

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Coma-inducing drug GHB may be reclassified.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Patients with alcohol problems

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

The role of gamma-hydroxybutyric acid in the treatment of alcoholism: from animal to clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Gamma-hydroxybutyrate: a role in the regulation of central dopaminergic neurons?

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Naloxone overcomes the dopaminergic, EEG, and behavioral effects of gamma-hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Coma induced by abuse of gamma-hydroxybutyrate (GBH or liquid ecstasy): a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Sites of action of gamma-hydroxybutyrate (GHB)--a neuroactive drug with abuse potential

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Gamma-hydroxybutyrate, a possible neurotransmitter.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900084-1

7 January 2021

10.1016/S0741-8329(99)00084-1

Identifiers

DOI

1 reference

30 July 2017

1 reference